Could This Be Pfizer’s Biggest Week At The US FDA For COVID Products?
Executive Summary
With an EUA submission for its Paxlovid treatment pill and expected authorization for universal adult vaccine boosters, Pfizer is establishing a portfolio of COVID products that could be used well after the eventual lifting of the public health emergency.